Lawrence Recht
Affiliations: | Stanford University, Palo Alto, CA |
Area:
Neurology & Clinical NeurosciencesGoogle:
"Lawrence Recht"Mean distance: 106866
Collaborators
Sign in to add collaborator| Chirag B Patel | collaborator | Stanford Medical School (Physics Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Iv M, Naya L, Sanan S, et al. (2023) Tumor treating fields increases blood-brain barrier permeability and relative cerebral blood volume in patients with glioblastoma. The Neuroradiology Journal. 19714009231207083 |
| Beinat C, Patel CB, Haywood T, et al. (2021) A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Beinat C, Patel C, Haywood T, et al. (2021) BIMG-13. A NOVEL RADIOPHARMACEUTICAL ([18F]DASA-23) TO MONITOR PYRUVATE KINASE M2 INDUCED GLYCOLYTIC REPROGRAMMING IN GLIOBLASTOMA Neuro-Oncology Advances. 3: i3-i4 |
| Sun J, Patel CB, Jang T, et al. (2020) High levels of ubidecarenone (oxidized CoQ) delivered using a drug-lipid conjugate nanodispersion (BPM31510) differentially affect redox status and growth in malignant glioma versus non-tumor cells. Scientific Reports. 10: 13899 |
| Jin MC, Liu EK, Shi S, et al. (2020) Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma. Frontiers in Oncology. 10: 337 |
| Datta K, Lauritzen MH, Merchant M, et al. (2019) Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model. Plos One. 14: e0225313 |
| Brown JM, Thomas R, Nagpal S, et al. (2019) Macrophage exclusion after radiation therapy (MERT): A new and effective way to increase the therapeutic ratio of radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 144: 159-164 |
| Zheng L, Zhang Y, Hao S, et al. (2019) A proteomic clock for malignant gliomas: The role of the environment in tumorigenesis at the presymptomatic stage. Plos One. 14: e0223558 |
| Thomas RP, Nagpal S, Iv M, et al. (2019) Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Iv M, Liu X, Lavezo J, et al. (2019) Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making. Ajnr. American Journal of Neuroradiology |